lular distribution (9) . FcRII(CD32) is expressed on most myeloid and lymphoid cells, while FCRIII(CD16) expression is restricted, appearing on NK cells, macrophages, and neutrophils . Recent studies have demonstrated that FcRIII(CD16) exists in two alternative membrane anchored forms, which result from tissue specific expression of two genes differing by single nucleotide substitutions (10) . A transmembrane anchored form of FcRIII(CD16) is expressed on NK cells and macrophages, demonstrating homology in its transmembrane and intracytoplasmic domains to murine FcR cx. The neutrophil molecule, in contrast, is anchored by a phosphatidylinositol linkage, yet is nearly identical in sequence to the NK molecule in its extracellular domains . These differentially anchored molecules respond to the same ligand with distinctly different responses . ADCC is mediated by the FcRIII(CD16) molecule on NK cells, yet the neutrophil receptor is unable to mediate this response independently (11) (12) (13) . In contrast, the structural diversity of human FcRII(CD32) has been largely underestimated . Previous reports have described the isolation of one complete cDNA clone (referred to here as FcRIIa) and a partial clone derived from a second gene (14) (15) (16) . Paradoxically, evolutionary conservation of human homologues for the murine a molecules appeared to be absent based on those reports . In this study we describe the characterization of multiple cDNA clones for FcRII(CD32) that arise from three distinct genes. One group of clones correspond to transcripts derived from a human homologue ofa 0 gene, here referred to as FcyRIIb, demonstrating conservation in sequence, alternative splicing pattern and tissue distribution to its murine counterpart . Another clone is derived from a gene referred to as FcyRIIa, which represents a chimera of a and a sequences, while a third FcyRII(CD32) gene and its corresponding transcript, referred to as FcyRIIa, has structural features of both FcyRIIa and IIb. The FcyRIIa and IIb molecules can be transfected into heterologous cells and express low affinity IgG binding molecules. Both the IIa and IIb gene products are recognized by mAbs ofthe CD32 cluster.
Materials and Methods
cDNA Isolation and Characterization. Human genomic FcyRII DNA fragments were isolated by screening ahuman genomic library constructed by partial Mbo I digestion ofhuman placenta DNA and ligated into the X phage vector CH28. 500,000 plaques were screened with a nick-translated 1.3-kb Pst I fragment containing the murine 01 FcyR cDNA insert (4) at reduced stringency (25% formamide, 5 x SSC, 7 mM Tris, pH 7.5, 10% dextran sulfate, and 25 lag/ml sheared salmon sperm DNA at 42'C). Two positive clones were identified, plaque purified, and further characterized by restriction mapping. A 1.3-kb Bgl II fragment was identified by its hybridization to the murine (31 cDNA and further analyzed by DNA sequence analysis. Two exons were found on that fragment that had 60% amino acid homology to the second extracellular and transmembrane domains of the murine 01 FcyR. Thus, by virtue of its homologous sequence and genomic organization, this 1.3-kb Bgl II fragment was determined to encode a human FcyRII gene fragment. This genomic fragment was used to isolate FcyRIIa from a Xgt 10 cDNA library (kindly provided by Drs . Xue-Dong Fan and B. Bloom, Albert Einstein College of Medicine, New York, NY) made from poly(A)' RNA isolated from the human monocyte-like U937 cell line (17) . FcyRIIbl and IIb2 were isolated from a Agt 10 cDNA library (kindly provided by Drs . A. Corbi and T. Springer, Center for Blood Research, Boston, MA) made from poly(A)' RNA isolated from PMAtreated HL-60 cells (18) . FcyRIb3 and the truncated FcyRIIb clone were isolated from a Xgt 10 cDNA library (kindly provided by Drs .J. DiSanto and N. Flomenberg, Sloan-Kettering Institute, New York, NY) made from Daudi poly(A)' RNA. FcyRIIb cDNAs were isolated using a radiolabeled overlapping oligonucleotide probe based on the previously published signal sequence of a partial IIb clone (16) . FcyRIIa was isolated from a genomic cosmid library by screening with mixed FcyRIIa and FcyIIb probes . Its corresponding transcript was isolated by reverse transcription followed by PCR amplification of neutrophil, monocyte, and lymphocyte RNA with oligonucleotide probes specific to the IIb 5' untranslated sequences and Hacytoplasmic sequences . All cDNA library screening was done as previously described (4) . For DNA sequencing cDNA inserts were subcloned into pUC-9 and both strands were sequenced by the chain termination method (19) .
Characterization of Cellular RNA . RNA isolation, poly(A) selection, and Northern blot analysis were performed as previously described (4) . In brief, RNA (2 jig poly(A)' RNA per sample in Fig. 6 , 10 lcg total RNA from primary cells) was fractionated on a 2.2 M formaldehyde-1 % agarose gel and transferred to nitrocellulose . The filter was hybridized at high stringency (50% formamide, 42°C) to probes consisting of overlapping oligonucleotides synthesized to the divergent signal sequences of each gene. Specific activities of 10' cpm/pg were obtained by labeling with a-[ 32P]dCTP and Escherichia coli polymerase (Klenow fragment) . Rehybridization of filters involved the removal of previously hybridized probe by heating at 65°C for 1 h in 50 mM Tris, pH 8.0, 2 mM EDTA, 1 x Denhardt's, and 0.5% sodium pyrophosphate.
For analysis ofcellular RNA by the polymerase chain reaction (PCR), 10 jig of total RNA was reverse transcribed into cDNA and amplified as previously described (10) with the following modifications . Oligonucleotides were made as described (10) to sequences in the 5' untranslated region or signal sequence and cytoplasmic domain or 3' untranslated region that allowed specific hybridization at an annealing temperature of 50°C . Aliquots of each amplification reaction were fractionated on agarose gels and subjected to Southern blot analysis as previously described (4) . Overlapping oligonucleotide probes made to distinct domains ofFcyRII sequences were labeled and hybridized as above to determine the structure of these PCR amplified cDNAs .
Cell Culture. Cell lines HL-60, U937, THP-1, and MOLT-4 were from American Type Culture Collection (Rockville, MD) . K562 was provided by Dr. R. Knowles; AW Ramos, Daudi, and Raji were provided by Dr. J. Lee; IM-9 was provided by Dr. O. Rosen; and Ltkcells were from Dr. N. Flomenberg all of Sloan-Kettering Institute (New York, New York) . K562, HL-60, U937, IM-9, and Ltk -cells were maintained in a-modified MEM supplemented with 10% FCS (Gibco Laboratories, Grand Island, NY) heat inactivated at 56°C for 30 min, 100 U/ml penicillin, and 100 pg/ml streptomycin . Daudi, Raji, AW Ramos, and MOLT-4 were maintained in RPMI 1640 supplemented with 25 mM Hepes, pH 7 .4, FCS, and antibiotics as above. THP-1 was grown in the same RPMI with 5 x 10-5 M /3-mercaptoethanol .
Primary cells including human monocytes, neutrophils, and NK cells were prepared as previously described (10) . B lymphocytes were prepared from a single human spleen by separating nonadherent mononuclear cells by Ficoll centrifugation and adhering to plastic twice (45 min, 37°C) . B lymphocytes were purified by negative selection using antiglobulin rosetting with a mixture of mAbs (CD16, CD56, CD3, CD14, CD5) to deplete T and NK cells . Populations were >95% purity by indirect immunofluorescence flow cytometry. Human term placenta was from a spontaneous vaginal delivery and immediately washed in PBS and frozen in liquid nitrogen .
Gene Transfer and Rosetting Assays. Coding sequences ofall FcyRII cDNAs were cloned into the Sma I site of the eukaryotic expression vector pCEXV3 . Transient and stable transfection and rosetting were done as previously described (7) . In brief, murine Ltk -cells were incubated with FcyRII/pCEXV3 plasmid and DEAE-dextran for 16 h, washed, and allowed to grow for 2 d before rosetting. Transfectants were assayed for rosette formation with TNP haptenated SRBCs opsonized with anti-DNP murine IgGl mAb (U-7-6 ; kindly provided by Dr. Zelig Eschar, Weizman Institute, Rehovot, Israel) . Stable transfectants were generated by calcium phosphate co-transfection with neomycin resistance conferring plasmid pGCcos3neo and selection with Geneticin (G418 ; Gibco Laboratories) as previously described (7) . Stable transfectants were selected by rosette formation with murine IgG1 opsonized SRBCs (above) orwith murine anti-FcyRII mAbs followed by SRBC conjugated with goat anti-mouse IgG Abs. m4bs and Indirect Immunofluorescence. mAbs used in this study were IV.3 (20) , KuFc79 (21) , and those of the CD32 cluster (22) including CIKM5, 2A1, KB61, and 41H16. 5 x 105 stable transfectant cells were incubated with 1 :500 dilutions of ascites for 45 min at 4°C. Cells were then washed in PBS with 2% FCS and 0.05% sodium azide three times at 40C. Affinitypurified, FITC-conjugated goat anti-mouse IgG (Boehringer Mannheim Biochemicals, Indianapolis, IN) was added to washed cells at 10 Ag/ml and incubated at 4°C for 45 min. Cells were washed as above and fixed in PBS/1 % formaldehyde. The samples were analyzed on a Becton Dickinson FACScan 1 cytofluorometer using a Consort 30 data analysis program .
Results
Isolation of cDNA Clones for TcRII(CD32). The structural homology of human FcRII(CD32) proteins to their murine counterparts was apparent in their ligand binding specificity for both murine and human IgG, their tissue distribution and apparent molecular mass. This structural relationship was exploited in the isolation ofhuman cDNA clones for this receptor class. DNA probes derived from the murine a and /3 cDNA sequences were used to screen human genomic libraries at reduced stringency, resulting in the isolation of genomic clones that, as shown by sequence analysis, demonstrated 60% sequence identity in the exons encoding the extracellular domains to their murine homologues (not shown). Probes derived from these exons were used to screen cDNA libraries constructed from RNA derived from hematopoietic cell lines that were positive for FcRII(CD32), as determined by their reactivity with mAbs specific for this receptor. The monocytic line U93 7, the promyelocytic line HL-60 (differentiated with PMA to macrophage-like cells) and the B lymphoid line Daudi were screened with these presumptive FcRII(CD32) probes and positive clones were characterized by DNA sequence analysis . A schematic representation of these clones is shown in Fig . 1 tained, designated IIa, IId, and IIb. As will be described below, while these clones demonstrate nearly identical extracellular and transmembrarie domains they differ considerably in the intracytoplasmic regions (IIa/a vs. IIb) predicted by these sequences. In addition, three distinct IIb clones have been isolated that are the result of alternative RNA splicing of both N112-terminal and COOH-terminal encoding exons.
Isolation andSequence Analysis of Human FeRILa cDNA . A U937 cDNA library was screened with the genomic FcyRII probe described above. Two positive phage were plaque purified and found to be identical by DNA sequence analysis . The complete nucleotide and predicted amino acid sequence of those FcyRIIa clones are shown in Fig. 2 . An open reading frame of 951 nucleotides, beginning at position 8, predicts a mature FcyRIIa protein of 282 amino acids of molecular mass of 31,276 daltons FIGURE 2 . The translated sequence of FcyRIIa is presented in one letter code above the nucleotide sequence, which is numbered at the right. A 35 amino acid signal sequence is predicted and numbered -35 to -1 with an overlined hydrophobic core. Cysteine residues predicted to form disulfide bridges are circled and N-linked glycosylation sites are boxed. A hydrophobic stretch of 24 amino acids presumed to span the membrane is overlined . An asterisk denotes the stop codon and two consensus polyadenylation sites are underlined.
SEQUENCE HETEROGENEITY OF HUMAN FvyRII (CD32)
that is identical to that reported previously (14) (15) (16) . The extracellular region is divided into two domains, each of which has homology to the Ig C2 set that centers around two highly conserved cysteine residues . Each extracellular domain retains one of the two sites for N-linked glycosylation that are found in the murine FcyRs to which this clone is homologous (discussed in detail below) . A 28 amino acid hydrophobic transmembrane domain is followed by a 76 amino acid intracellular region . The 3' untranslated region of FcyRIIa contains two consensus polyadenylation signals at positions 1352 and 2356 (underlined in Fig. 2) . The presence of a stretch of A residues that are not encoded in genomic DNA downstream of the second AATAAA indicates that this clone was derived from a mRNA that was poiyadenylated just after this site .
Isolation and Analysts of FcyRIIb cDAAs. The isolation of FcyRIIb cDNAs was achieved by screening Xgt10 cDNA libraries made from the B cell line Daudi and a macrophage-like cell line obtained by phorbol ester-induced differentiation of HL-60 cells. Multiple clones were isolated from each library and subjected to restriction mapping, which revealed four unique groups of cDNAs. Representatives of each group were purified and their cDNA inserts were subjected to DNA sequence analysis . These clones are shown schematically in Fig. 1 ; DNA sequences of three cDNAs with unique coding regions are shown in Fig. 3 . A fourth incompletely processed cDNA is discussed below. The 1.5-kb FcyRIIb2 cDNA (Fig . 1) contains an open reading frame beginning at position 81 (Fig . 3) that predicts a protein of 247 amino acids (Fig . 4) . A 44 amino acid signal sequence is predicted to be removed from this precursor generating a mature protein of 27,178 daltons. The extracellular domains of this protein and FcyRIIa are highly related, having 96% amino acid identity. This identity includes the four cysteines (circled in Fig. 4 ) that are predicted to form two disulfide-bridged Ig-like domains. FcyRIIb2 predicts three N-linked glycosylation sites in the extracellular region . The predicted transmembrane anchor contains a hydrophobic core of 23 amino acids followed by a basic stop transfer sequence arg-lys-lys-arg. A 44 amino acid intracellular region, largely unrelated to FcyRIIa, predicted by this cDNA is particularly rich in acidic residues (23%, Fig.  4 ) . The FcyRIIb2 cDNA has a 3' untranslated region of 487 residues that ends one nucleotide after the poly(A) addition signal underlined in Fig. 3 .
FcyRIIbl is a cDNA sequence of 1,417 nucleotides that is incomplete in that it lacks sequences predicting the NH2-terminal 19 amino acids of signal sequence found in FcyRIIb2 . However, genomic DNA sequence analysis indicates that FcyRIIbl begins in the middle of an exon that encodes signal sequences in all other FcyRIIb cDNAs (Qiu, W Q, andJ. V. Ravetch, unpublished observations). It is likely, therefore, that this clone was truncated during construction of the cDNA library. FcyRIIbl is identical to IIb2 from positions 139 through 840 (Fig . 3) , which corresponds to sequences encoding the extracellular, transmembrane, and the beginning of the intracellular region. At that position a 57 nucleotide insertion is found in the FcyRIIbl cDNA after which the two sequences are once again identical through the end of the coding regions. This insertion maintains the open reading frame and is known from genomic cloning to correspond precisely to an exon . These observations, together with the fact that a 74% amino acid identity to murine FcyR at exists between these sequences, support identification of this insertion as an alternatively spliced "on. To confirm the existence of these two (FcyRIIbl and IIb2) alterna-fcrIIb3 gccctctaggqtaqaatcgccaagctttgagagaagqctqt " ****** +"" *++ *.+x* .. . "** fcrIIb2 gactgctgtqctctgggcgccagc 65 fcrIIb2 tcgctccagggagtgATGGGAATCCTGTCATTCTTACCTGTCCTTGCCACTGAGAGTGACTGGGC 130
fcrIIb3 ' '--fcrIIb2 TGACTGCAA""* " "**** fcrIIbl ***~**GTCCCCCCAGCCTTGGGGTCATATGCTTCTGTGGACAGCTGTGCTATTCCTGGCTC 195 """** "" ********** .."" *******"""" *" *"*"****** ".*** x****** .* " fcrIIb2 * **** " **** """*xxx* " * fcrIIbl tgctcqagttccaaaagagaaggtttcttccagagtcatctacctgaqtcctgaaqctccctgtc 1170 fcrIIb3 " x******+******* "" *****+* "" ***xx .*****x fcrIIb2 fcrIIbl ctgaaagccacagacaatatggtcccaaataaccqactqcacctqctqtcttcagctcttcttga 1235 fcrIIb3 fcrIIbZ * **~, .** "" ..,******* fcrllbl catcaaggctcttccgttccacatccacacagccaatccaattaatcaaaccactgttattaaca 1300 fCrIIb3 fcrIIb2 fcrIIbl gataatagcaacttqggaaatgcttatgttacagqttaccgttqagaacaatcatctaaatctat 1365 fcrIIb3 fcrIIb2 fcrIIbl atgatttcagaaatgttaaaatagactaacctctaccagcacattaaaagtgattgtttctggqt 1430 fcrIIb3 fcrIIb2 "" """""ttattgatgatttttattttctttatttttctataaagatcatatattacttttata 1495 fcrIIbl gataaaaaaaaaaaaaaaaaaaaaaa fcrIIb2 aaaa 1500 FIGURE 3. Nucleotide sequences of three alternatively spliced forms of FcyRIlbcDNAs. Numbers in the right hand margin are arbitrary in that they denote positions in the composite sequence only and do not correspond to a particular cDNA. Untranslated regions are indicated in lower case while coding regions are shown in upper case. Asterisks indicate identity with the nucleotide below, while hyphens indicate the absence of a nucleotide in an alternatively spliced exon . The consensus polyadenylation site is underlined . These sequence data have been submitted to the EMBL/GenBank Data Libraries.
fcrIib3 " ------fcrIlb2 NGIISFLPVUTESDWADC """""""+""""""*+" """""*" +** ., .*+.****** fcrIIb3 " "+ "" """" fcrIlb2 ---__---___ "** .***+* .+*****++, fcrIIbl CREHGETLPEKPANPTNPDEADKVGAENTITYSLIIIHPDALEEPDDQNRI 266 tively spliced messages in authentic cellular RNA, FcyRIIb-specific oligonucleotide primers were annealed to RNA extracted from myeloid and lymphoid cells, converted to cDNA by reverse transcription and the resulting DNA stand was amplified by the PCR. Sequence analysis of these cDNAs confirmed the existence of alternatively spliced messages that correspond precisely to FcyRIIbl and IIb2 (not shown) . FcyRIIbl ends with 19 A residues that are not encoded in the known FcyRIIb gene. This sequence presumably represents a poly(A) tail in the mRNA that gave rise to this clone, although no consensus polyadenylation signal is found in preceding sequences (discussed below) . The cDNA termed FcyRIIb3 in Figs . 1 and 3 contains an open reading frame of 931 nucleotides beginning at position 81 that predicts a mature protein of 29,277 daltons (like FcyRIIbl). The feature that distinguishes FcyRIIb3 from previously discussed cDNAs of this subclass is the deletion of 21 nucleotides (193-213 in Fig.  3 ) that predict the last seven amino acids of the signal sequence (Fig. 4) . Genomic sequence analysis indicates that the missing nucleotides correspond precisely to an exon that is located between exons encoding the NH2-terminal sequences of the signal sequence and the first extracellular domain, suggesting that this difference results from an alternative splicing event. It should be noted that the exon that is spliced out in FcyRIIb3 encodes amino acids contributing to the hydrophobic core of the signal sequence of a nascent FcyRIIb protein (Fig . 4) . A similar situation has been described for transcripts of the ct subunit gene of the rat high affinity IgE receptor. A 21-bp exon encoding the COOH-terminal sequences of the signal sequence undergoes alternative splicing, as defined by cDNA analysis of mast cell RNA (23) .
These studies demonstrate that primary transcripts from the FcyRIIb gene undergo alternative splicing at both the 5' end to generate FcyRIIb3 and at the 3' end to generate the alternative cytoplasmic domains exemplified by FcyRIIbl and IIb2 .
In addition to these clones containing complete coding sequences, we have isolated a truncated FcyRIIb cDNA that lacks sequences encoding the cytoplasmic region of these receptors. This truncated clone is identical to FcyRIIb2 from the 5' untranslated region through sequences predicting the transmembrane domain (po-sitions 67-840 in Fig. 3 ) at which point it diverges completely. The divergent sequence is identical to that of the genomic intron of this region and to that of the previously isolated cDNA of this subclass (16) , suggesting that both cDNAs represent incompletely processed pre mRNAs.
Isolation andAnalysis ofFcyRIIa'. A minimum of three distinct genes encode FcyRII transcripts . Overlapping cosmid clones encoding human FcyRII genes have been isolated and analyzed . The sequence of those clones confirms that Fc'YRIIa derives from one gene and that the FcyRIlb sequences (1, 2, and 3) are derived from alternative splicing of a second gene (Qiu, W. Q, andJ. V. Ravetch, unpublished observations) . A third FcyRII gene was identified that is composed of the 5' exons of an FcyRIlb-like gene (5' untranslated, signal, extracellular, and transmembrane) and the 3' exons of an FcyRIIa-like gene (cytoplasmic and 3' untranslated ; Qiu, W Q, and J . V. Ravetch, unpublished observations). This gene is predicted to give rise to transcripts that are structurally distinct from the FcyRIIa and IIb molecules discussed above. A cDNA clone was isolated from a Daudi library and characterized. Its sequence indicated that it represented an incompletely processed transcript of this IIa' gene, lacking only the last cytoplasmic and 3' untranslated sequences. To test for the presence of a complete transcript, cellular RNAs were characterized by reverse transcription and PCR amplification using a 3' cytoplasmic domain oligonucleotide from FcyRIIa and a 5' untranslated region oligonucleotide from FcyRIlb. A cDNA product of the expected size and structure was obtained (Fig . 1 ) in neutrophil monocytic and B lymphoid cell RNAs as confirmed by hybridization to domain specific probes (data not shown) . The sequence of IIa' is >99% identical to IIb from the 5' untranslated through the transmembrane domain . The cytoplasmic and 3' untranslated sequences, however, are >95% identical to IIa (data not shown) .
Sequence Homology between Murine andHuman FcyRIIs. Comparisons of human and mouse FcyRII cDNAs shown in Fig. 5 (nucleotide) and Table I (amino acid) reveal both striking homology and significant differences. Dot matrix comparison of the human FcyRIIb2 cDNA sequence with that of its murine homologue (Fc,YRa2) shows that they are related throughout their length, as shown in Fig. 5 D. From a high of 75% in the extracellular region, these sequences retain >50% nucleotide identity in 5' and 3' noncoding regions. In a similar fashion, comparison of human FcyRIIbl with its murine homologue FcyR (3, shows the close relationship between these gene products . However, a deletion of 81 nucleotides in the cytoplasmic domain of FcyRIIbl is apparent relative to its murine counterpart (Fig . 5 C) . In contrast, comparison of human FcyRIIa and murine FcyR cx (Fig . 5 B, Table I ) reveals a markedly different pattern. Those transcripts demonstrate homology in nucleotide sequences predicting the signal sequence and extracellular domains. However, the transmembrane, cytoplasmic, and 3' untranslated regions of these two clones share no homology.
The evolutionary relationship of FcyRIIa/d with its murine counterpart is evident from the two regions of homology that are found between human FcyRIIa/a and IIb (or murine /3, not shown) (Fig. 5 A) . The first region begins with nucleotide sequences that predict the extracellular region and continues through the membrane spanning domain and into the first portion of the cytoplasmic region (Table I) Amino Acid Sequence Homology Between Human and Mouse FcyRII huFcyRIIa cytoplasmic domain is encoded by 2 exons, the shorter NH2-terminal exon is 60% identical to huFcyRIIb2 and 37°ío identical to moFCYRß2 . The longer COOH-terminal region is unrelated to either of these cDNAs resulting in a nonsignificant overall homology . FcyRIIa/a' and in sequences encoding the cytoplasmic domain ofFcyRIIb2 and extends through the end of both clones (Fig. 5 A, see Discussion) . In view of the extern sive homology between FcyRIIb2 and its murine homologue 02 (Fig. 5 D) the latter cDNA also shares a strong homology with the 3' untranslated region of FcyRIIa/a. FcyRIIa, though not IIa, has a chimeric organization, with distinct regions that are homologous to either of the two murine FcyRs. The FcyRIIa signal sequence is homologous only to the murine ci FcyR (Fig. 5 B) , with both IIa and IIa' demonstrating homology in their extracellular region to both murine a and (3 sequences, while their transmembrane, some of the cytoplasmic and 3' untranslated regions are homologous to the murine (32 FcyR or its human homologue FcyRIIb2 (Table  I and Fig. 5 A) . FcyRs Display Distinct Patterns of mRNA Expression. To determine if these structurally distinct molecules displayed different patterns of mRNA expression, as in the mouse (4), oligonucleotide probes to the signal sequences of FcyRIIa and IIb were used to reveal distinct patterns of mRNA expression by Northern analysis . FcyRIIa transcripts are expressed in monocyte-like cell lines (Fig. 6 A, lanes 3-7) , HL-60 differentiated with DMSO ( Fig. 6 A, lane 2) , and in the erythroleukemic cell line K562 (Fig. 6 A, lane 1) . Four lymphoid cell lines do not express FcyRIIa mRNA (Fig. 6 A lanes 9-12) although the Burkitt lymphoma cell line Daudi does ( A, lane 8). As shown in Fig. 6 A, the human FcyRIIa-specific signal probe reveals two bands of 2.6 and 1.5 kb in all positive cell lines. A cDNA probe to sequences 3' of the first polyadenylation signal of FcyRIIa (see Figs. 1 and 2 ) hybridized only to the 2 .6-kb transcript (data not shown), suggesting that these two transcripts arise from differential polyadenylation . In contrast to IIa, the FcyRIIb signal probe detects a band of 1.5-1 .6 kb that is expressed in numerous lymphoid and myeloid cell lines as shown in Fig. 6 B (lanes 3-11) . Among cell lines that have been tested, only K562 (lane 1), MOLT-4 (lane 12), and DMSO-treated HL-60 (lane 2) do not express FcyRIIb mRNA . However, the IIb signal probe cannot distinguish between IIa and IIb since the predicted FcyRIIa transcript, identified in neutrophils, monocytes, and lymphocytes, possesses a FcyRIIb-like signal . These transcripts can, however, be distinguished using PCR and distinct combinations of oligonucleotides as described above (Materials and Methods). In this manner, IIa' expression has been detected in neutrophils, B lymphocytes, cultured adherent monocytes, U937 cells, and placenta, but not in T lymphoid cell line RNAs (data not shown) . To confirm results obtained with cell lines total RNAs from primary human cells were analyzed for FcyRII expression (not shown) . Neutrophils, cultured adherent monocytes, and chronic myelogenous leukemia cells all expressed abundant FcyRIIa mRNA by Northern analysis. Human placenta, a rich source of monocyte and macrophagelike cells, expressed readily detectable FcyRIIa and IIb mRNA on Northern blots. In contrast FcyRIIb mRNA could only be detected in B lymphocytes, cultured adhert monocytes, and neutrophils by reverse transcription and PCR amplification of these primary cell RNAs .
Immune Complexes ofIgG and mAbs Bind Human FcyRII Expressed by Gene Transfer. The ligand binding properties and epitopes of FcyRII proteins predicted by these cDNAs were determined by the expression of these clones in FcyR -fibroblast cells. Transient transfection of murine Ltk-fibroblasts with FcyRII cDNAs cloned into an SV40-based vector (pCEXV3) resulted in cell surface expression of all FcyRs discussed above. Positive transfectants were detected by binding of mouse IgGI opsonized SRBCs indicating the capacity of these FcyRs to bind multivalent immune complexes (Fig. 7) . FcyRIIa (Fig. 7 A) demonstrates a consistently decreased level of mouse IgG1 rosetting. This difference is not due to a difference in the efficiency of cell surface expression of the protein encoded by this cDNA, since rosetting with mAb IV.3 (20)-coupled erythrocytes gave equivalent densities of bound cells (not shown) . Rather, these data suggest that FcyRIIa has a decreased affinity for mouse IgGI compared with FcyRIIb. FcyRIb3, lacking part of the hydrophobic core of its signal sequence, yields transfectants with an equivalent density of bound mouse IgGI-or CD32 mAb-coated SRBCs, indicating the functional integrity of the surface FcyRII molecule . The functional consequences of this alternative splice is not apparent and is under investigation .
Characterization of these sequences as encoding authentic FcyRII proteins was determined by epitope mapping using well-characterized mAbs (20) (21) (22) that define this class of molecules. Murine fibroblasts stably expressing human FcyRs were assayed by indirect immunofluorescence and flow cytometry for recognition by antiFcRII mAbs . All CD32 mAbs (22) and the mAbs IV3 (20) and KuFc79 (21) recognized both FcyRIIa and IIb transfectants (not shown) . 
Discussion
In this article we establish the structural heterogeneity of human FcyRII molecules. Previous studies using IgG affinity binding and an anti-FcyRII mAb (20) suggested that this class of molecules was more heterogeneous than could be accounted for by the expression pattern of the previously isolated FcyRII cDNA (14-16 ; this article). Cloning of multiple cDNAs representing alternatively spliced transcripts of the FcyRIIb gene and identification of the IIa' transcript complement the previously isolated cDNA as subclasses of this important class of receptors. Overlapping yet distinct subsets of cell lines express mRNAs encoding these receptors. This pattern of RNA expression is consistent with the distribution of FcyRII protein determined by mAb and ligand binding studies. Both a and b subclasses of FcyRII have been shown by gene transfer to bind immune complexes and be recognized by anti-FcRII mAbs. Together these three subclasses account for all ligand and mAb binding attributed to human FcRII to date.
Human FcyRIIa, IIa' and IIb cDNAs predict proteins that are closely related yet have important structural differences . In particular, the mature proteins predicted by FcyRIIa and IIa genes are >95% identical throughout . Receptors predicted by the FcyRIIb cDNAs share this homology with IIa/IIa' in the extracellular domain accounting for their ability to bind common ligands and mAbs. Unlike their murine counterparts the human receptors display high homology in their transmembrane domains (Table I ). While 10 ofthe first 12 residues of their intracellular regions are identical, FcyRIIaJa' and IIb2 diverge completely at that point . The largely divergent cytoplasmic tails of these receptors may mediate distinct functions in response to binding a common ligand.
Both conservation and divergence in primary structure of members of the murine and human FcyR multigene families lead to important predictions about their functions. A striking conservation of sequence is observed between human FcyRIIb and murine FcyR a. A human gene encoding FcyRIIb has an identical exon-intron organization to that ofthe FcyR 0 gene (Qiu, W Q, and J. V. Ravetch, unpublished observations) . In both species there is alternative splicing of the primary transcripts from these genes that involves their first cytoplasmic exons. The human FcyRIb2 and murine FcyR /32 cDNAs lacking these exons are homologous throughout their coding and noncoding regions (Fig. 6 D) . In contrast, the cDNA molecules including these exons reveal an interspecies divergence (Fig. 6 C) . In human FcyRIIbl there is a deletion of sequences corresponding to the COOH-terminal 27 amino acids of the first cytoplasmic exon of murine FcyR al, a result of the utilization of a cryptic splice donor site in this sequence . Surprisingly, this same sequence AGGT GAGT is present in the murine homologue (4), yet its use as a splice donor has not been detected.
In contrast, a direct relationship between human FcyRIIa, IIa, and a single murine counterpart is not obvious . Analysis of both cDNA and genomic sequence data for FcyRIIa and IIa' indicates that the sequence preceding the second region of homology between FcyRIIa/a and murine FcyR (32 (or human FcyRIIbl, Fig . 5 A) could be a mutated splice acceptor site. In particular, a T residue inserted into the critical AG splice acceptor dinucleotide (Fig. 8) would have rendered that site nonfunctional. With the utilization of a cryptic splice site in the intron preceding this site, these sequences persist as exon in FcyRIIa/a' transcripts . Therefore, the nucleo- tide sequences for both coding regions and 3' untranslated sequences ofmurine FcyR 0 and human FcyRIIb (Fig . 5 A) are homologous to the 3' untranslated region of human FcyRIIa/d because of the presence of the ancestral cytoplasmic/3' untranslated exon in the latter sequence (Fig . 8) . The novel exon found in the FcyRIIa/a' gene likely results from these events having converted sequences 3' of the new acceptor site, which are intron sequences in IIb and mouse S, to exon sequences in IIa/a: Thus, IIa most likely arose from an ancestral IIb gene by mutation of a splice acceptor site and utilization of a cryptic site . The persistence of those sequences as an open reading frame for the cytoplasmic domain of the human Ha/a' transcript suggests the acquisition of a functional role for these sequences. The chimeric structure of FcyRIIa noted above (Fig. 5, A and B) suggested that the transcript from which this cDNA was obtained is the product of a gene that arose by recombination between two genes that were precursors of the present day murine Fc'YRa and 0 genes. Such an event would explain the murine FcyR alike signal sequence and murine FcyR02-(or human Fc7RIb2) like transmembrane, first cytoplasmic portion, and 3' untranslated regions noted above and by others (16) .
Selective functions for FcyRs IIa, Ila, and IIb are further suggested by the cell type-specific expression of these three genes. RNA expression from these genes has been distinguished through use ofsignal sequence probes that are specific for FcyRIIa and FcyRs IIa'/IIb and by the use of reverse transcription and PCR to distinguish IIa' from IIb. Monocyte/macrophage-like human cells including cultured adherent monocytes and cell lines such as U937 express all three subclasses of FcyRII . Peripheral blood neutrophils express readily detectable FcyRIIa mRNA with a lower level of FcyRIIb and FcyRIIa' mRNA. Splenic B lymphocytes and cell lines of B lymphoid origin (IM-9, Daudi, Raji, AW Ramos) all express FcyRIIb mRNA, a finding that is consistent with the ubiquitous lymphocyte expression of the murine homologue, FcyR a (4). Three human T cell lines (MOLT4, Jurkat, and Fro-2) fail to express detectable levels of human FcyRII mRNA. While these patterns of RNA expression are consistent with previous studies of RNA (14) (15) (16) and protein expression (reviewed in references 1 and 9) for FcyRII (CD32), those studies failed to distinguish between subclasses of the FcyRII(CD32) family as demonstrated here. Recognition ofthe structural differences among these molecules and their specificities of cellular expression suggest functionally important distinctions .
Summary
The structural heterogeneity of the human low affinity receptor for IgG, FcRII(CD32), has been elucidated through the isolation, characterization, and expression of cDNA clones derived from myeloid and lymphoid RNA. These clones predict amino acid sequences consistent with integral membrane glycoproteins with single membrane spanning domains. The extracellular domains display sequence homology to other FcyRs and members of the Ig supergene family. A minimum ofthree genes (FcyRIIa, IIa, and FcyRIIb) encode these transcripts, which demonstrate highly related extracellular and membrane spanning domains. IIa/IIa' differ substantially in the intracytoplasmic domain from IIb. Alternative splicing of the IIb gene generates further heterogeneity in both NH2-and COOH-terminal domains of the predicted proteins . Comparison to the murine homologues of these molecules reveals a high degree of conservation between the products ofone of these genes, FcyRIIb, and the murine 0 gene in primary sequence, splicing pattern, and tissue distribution . In contrast, the sequence of IIa' indicates its relationship to the 0-like genes, with mutation giving rise to a novel cytoplasmic domain, while IIa is a chimera of both a-and 0-like genes. Expression of these cDNA molecules by transfection results in the appearance of IgG binding molecules that bear the epitopes defined by the FcRII(CD32) mAbs previously described.
